Lack of Antilipoprotein Lipase Antibodies in Takayasu's Arteritis
Open Access
- 1 January 2009
- journal article
- research article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2009, 1-4
- https://doi.org/10.1155/2009/803409
Abstract
Background. Antilipoprotein lipase (anti-LPL) antibodies were described in rheumatic diseases. In systemic lupus erythematosus they were highly associated with inflammatory markers and dyslipidemia, and may ultimately contribute to vascular damage. The relevance of this association in Takayasu's arteritis, which is characterized by major inflammatory process affecting vessels, has not been determined.Objectives. To analyze the presence of anti-LPL antibodies in patients with Takayasu's arteritis and its association with inflammatory markers and lipoprotein risk levels.Methods. Thirty sera from patients with Takayasu's arteritis, according to ACR criteria, were consecutively included. IgG anti-LPL was detected by a standard ELISA. Lipoprotein risk levels were evaluated according to NCEP/ATPIII. Inflammatory markers included ESR and CRP values.Results. Takayasu's arteritis patients had a mean age of 34 years old and all were females. Half of the patients presented high ESR and 60% elevated CRP. Lipoprotein NCEP risk levels were observed in approximately half of the patients: 53% for total cholesterol, 43% for triglycerides, 16% for HDL-c and 47% for LDL-c. In spite of the high frequency of dyslipidemia and inflammatory markers in these patients no anti-LPL were detected.Conclusions. The lack of anti-LPL antibodies in Takayasu's disease implies distinct mechanisms underlying dyslipidemia compared to systemic lupus erythematosus.Keywords
Funding Information
- Federico Foundation
This publication has 32 references indexed in Scilit:
- Atherosclerosis in Autoimmune Rheumatic Diseases—Mechanisms and Clinical FindingsClinical Reviews in Allergy & Immunology, 2008
- Subclinical Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus ErythematosusThe American Journal of Medicine, 2008
- Anti–lipoprotein lipase antibodies: A new player in the complex atherosclerotic process in systemic lupus erythematosus?Arthritis & Rheumatism, 2004
- Lipid metabolism in womenProceedings of the Nutrition Society, 2004
- Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosusArthritis & Rheumatism, 2002
- Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications.Cleveland Clinic Journal of Medicine, 2002
- Sepsis: menu of new approaches replaces one therapy for all.Cleveland Clinic Journal of Medicine, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Lipid and Apolipoprotein Profiles of Uremic Dyslipoproteinemia -Relation to Renal Function and DialysisNephron, 1991
- The American College of Rheumatology 1990 criteria for the classification of takayasu arteritisArthritis & Rheumatism, 1990